US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist
  • 1.6000
  • +0.0300+1.91%
Close May 20 16:00 ET
  • 1.5700
  • -0.0300-1.88%
Post 19:57 ET
201.21MMarket Cap-6666P/E (TTM)

Atossa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
33.10%-4.7M
-0.87%-20.94M
-23.17%-5.57M
28.23%-3.88M
24.95%-4.47M
-43.95%-7.02M
-26.03%-20.76M
-23.41%-4.52M
-76.68%-5.41M
-11.47%-5.95M
Net income from continuing operations
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
22.25%-6.23M
-47.35%-9.83M
-31.24%-6.28M
-30.84%-26.96M
-55.03%-7.49M
-54.17%-8.01M
5.23%-6.67M
Operating gains losses
--2K
----
----
----
----
----
--3K
--0
--2K
----
Depreciation and amortization
66.67%5K
187.50%23K
600.00%14K
50.00%3K
50.00%3K
50.00%3K
-65.22%8K
0.00%2K
-66.67%2K
-66.67%2K
Change In working capital
132.63%756K
353.59%1.52M
16.12%1.65M
52.04%1.42M
173.10%769K
-21.95%-2.32M
48.18%-599K
413.00%1.42M
178.21%932K
-318.26%-1.05M
-Change in receivables
----
125.84%743K
121.05%28K
144.48%709K
----
----
175.29%329K
2.92%-133K
345.76%290K
-139.18%-232K
-Change in prepaid assets
116.99%664K
201.15%2.81M
1,558.44%2.25M
1,060.91%2.29M
-42.24%-2.03M
122.08%306K
-311.42%-2.77M
74.55%-154K
-61.30%197K
-999.37%-1.43M
-Change in payables and accrued expense
102.58%69K
-186.58%-2.12M
-99.63%10K
115.54%143K
-72.38%401K
-235.43%-2.67M
432.46%2.44M
86.89%2.71M
-707.02%-920K
257.64%1.45M
-Change in other current assets
--0
-184.25%-1.7M
-143.55%-2.42M
-223.96%-1.7M
380.81%2.42M
100.88%1K
-14.59%-597K
14.78%-992K
2,144.26%1.37M
---860K
-Change in other current liabilities
-50.00%23K
89,300.00%1.78M
22,375.00%1.78M
-525.00%-25K
-205.56%-19K
675.00%46K
-111.76%-2K
-366.67%-8K
-33.33%-4K
28.57%18K
Cash from discontinued investing activities
Operating cash flow
33.10%-4.7M
-0.87%-20.94M
-23.17%-5.57M
28.23%-3.88M
24.95%-4.47M
-43.95%-7.02M
-26.03%-20.76M
-23.41%-4.52M
-76.68%-5.41M
-11.47%-5.95M
Investing cash flow
Cash flow from continuing investing activities
-6K
99.70%-14K
0
99.96%-1K
-13K
0
-52,422.22%-4.73M
-2.01M
-29,966.67%-2.71M
0
Net PPE purchase and sale
---6K
48.15%-14K
--0
83.33%-1K
---13K
--0
-200.00%-27K
---8K
33.33%-6K
--0
Net investment purchase and sale
----
--0
--0
----
----
----
---4.7M
---2M
----
----
Cash from discontinued investing activities
Investing cash flow
---6K
99.70%-14K
--0
99.96%-1K
---13K
--0
-52,422.22%-4.73M
---2.01M
-29,966.67%-2.71M
--0
Financing cash flow
Cash flow from continuing financing activities
204K
-1.48M
0
0
0
0
Net common stock issuance
----
---1.48M
--0
----
----
----
--0
--0
----
----
Proceeds from stock option exercised by employees
--204K
----
----
----
----
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--204K
---1.48M
--0
---1.48M
--0
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
-20.21%88.57M
-18.67%111M
-19.86%94.14M
-20.81%99.5M
-20.99%103.98M
-18.67%111M
244.11%136.49M
-16.18%117.48M
-11.85%125.65M
-4.42%131.6M
Current changes in cash
35.92%-4.5M
11.99%-22.43M
14.70%-5.57M
33.97%-5.36M
24.73%-4.48M
-43.57%-7.02M
-126.32%-25.49M
-78.25%-6.53M
-239.30%-8.12M
-222.43%-5.95M
End cash Position
-19.15%84.07M
-20.21%88.57M
-20.21%88.57M
-19.86%94.14M
-20.81%99.5M
-20.99%103.98M
-18.67%111M
-18.67%111M
-16.18%117.48M
-11.85%125.65M
Free cash flow
33.01%-4.7M
-0.81%-20.96M
-22.95%-5.57M
28.29%-3.88M
24.73%-4.48M
-43.57%-7.02M
-26.13%-20.79M
-23.63%-4.53M
-76.36%-5.42M
-11.47%-5.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 33.10%-4.7M-0.87%-20.94M-23.17%-5.57M28.23%-3.88M24.95%-4.47M-43.95%-7.02M-26.03%-20.76M-23.41%-4.52M-76.68%-5.41M-11.47%-5.95M
Net income from continuing operations 6.42%-5.88M-11.62%-30.09M-3.51%-7.75M22.25%-6.23M-47.35%-9.83M-31.24%-6.28M-30.84%-26.96M-55.03%-7.49M-54.17%-8.01M5.23%-6.67M
Operating gains losses --2K----------------------3K--0--2K----
Depreciation and amortization 66.67%5K187.50%23K600.00%14K50.00%3K50.00%3K50.00%3K-65.22%8K0.00%2K-66.67%2K-66.67%2K
Change In working capital 132.63%756K353.59%1.52M16.12%1.65M52.04%1.42M173.10%769K-21.95%-2.32M48.18%-599K413.00%1.42M178.21%932K-318.26%-1.05M
-Change in receivables ----125.84%743K121.05%28K144.48%709K--------175.29%329K2.92%-133K345.76%290K-139.18%-232K
-Change in prepaid assets 116.99%664K201.15%2.81M1,558.44%2.25M1,060.91%2.29M-42.24%-2.03M122.08%306K-311.42%-2.77M74.55%-154K-61.30%197K-999.37%-1.43M
-Change in payables and accrued expense 102.58%69K-186.58%-2.12M-99.63%10K115.54%143K-72.38%401K-235.43%-2.67M432.46%2.44M86.89%2.71M-707.02%-920K257.64%1.45M
-Change in other current assets --0-184.25%-1.7M-143.55%-2.42M-223.96%-1.7M380.81%2.42M100.88%1K-14.59%-597K14.78%-992K2,144.26%1.37M---860K
-Change in other current liabilities -50.00%23K89,300.00%1.78M22,375.00%1.78M-525.00%-25K-205.56%-19K675.00%46K-111.76%-2K-366.67%-8K-33.33%-4K28.57%18K
Cash from discontinued investing activities
Operating cash flow 33.10%-4.7M-0.87%-20.94M-23.17%-5.57M28.23%-3.88M24.95%-4.47M-43.95%-7.02M-26.03%-20.76M-23.41%-4.52M-76.68%-5.41M-11.47%-5.95M
Investing cash flow
Cash flow from continuing investing activities -6K99.70%-14K099.96%-1K-13K0-52,422.22%-4.73M-2.01M-29,966.67%-2.71M0
Net PPE purchase and sale ---6K48.15%-14K--083.33%-1K---13K--0-200.00%-27K---8K33.33%-6K--0
Net investment purchase and sale ------0--0---------------4.7M---2M--------
Cash from discontinued investing activities
Investing cash flow ---6K99.70%-14K--099.96%-1K---13K--0-52,422.22%-4.73M---2.01M-29,966.67%-2.71M--0
Financing cash flow
Cash flow from continuing financing activities 204K-1.48M0000
Net common stock issuance -------1.48M--0--------------0--0--------
Proceeds from stock option exercised by employees --204K------------------0----------------
Cash from discontinued financing activities
Financing cash flow --204K---1.48M--0---1.48M--0--0--0--0--0--0
Net cash flow
Beginning cash position -20.21%88.57M-18.67%111M-19.86%94.14M-20.81%99.5M-20.99%103.98M-18.67%111M244.11%136.49M-16.18%117.48M-11.85%125.65M-4.42%131.6M
Current changes in cash 35.92%-4.5M11.99%-22.43M14.70%-5.57M33.97%-5.36M24.73%-4.48M-43.57%-7.02M-126.32%-25.49M-78.25%-6.53M-239.30%-8.12M-222.43%-5.95M
End cash Position -19.15%84.07M-20.21%88.57M-20.21%88.57M-19.86%94.14M-20.81%99.5M-20.99%103.98M-18.67%111M-18.67%111M-16.18%117.48M-11.85%125.65M
Free cash flow 33.01%-4.7M-0.81%-20.96M-22.95%-5.57M28.29%-3.88M24.73%-4.48M-43.57%-7.02M-26.13%-20.79M-23.63%-4.53M-76.36%-5.42M-11.47%-5.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg